Cambridge Isotope Laboratories, Inc. (CIL), a global supplier of stable isotopes and stable isotope-labeled compounds for analytical and research applications , recently began a significant capacity optimization of one of the production cascades at the carbon-13 (¹³C) separation facility in Xenia, Ohio. This optimization, which began this past summer and is scheduled for completion in the summer of 2021, will increase the cascade's ¹³C production by 10%. This follows the most recent expansion completion earlier this year, which increased ¹³C production capacity by 25%. CIL supplies ¹³C and ¹³C-urea which is used in diagnosis of Helicobacter infection.

CIL's isotope-separation facility houses the world's largest ¹³C and one of the world's largest ¹⁸O(Oxygen-18) isotope-separation facilities and also has the world's only commercial D₂O(Heavy water) enrichment columns.

To read more please visit:

https://www.prnewswire.com/news-releases/cambridge-isotope-laboratories-inc-announces-13c-cascade-production-optimization-at-ohio-plant-301193840.html

Source: Cambridge Isotopes Laboratories, Inc.